High-Performance Dual Combination Therapy for Cancer Treatment with Hybrid Membrane-Camouflaged Mesoporous Silica Gold Nanorods
Authors:
- 16 December 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (52) , 57732-57745
Abstract
Conventional chemotherapy usually induces significant side effects due to its inability to discriminate between cancer and normal cells. Moreover, the efficacy of cancer elimination is still unsatisfied. Here, we fabricated a nanocomposite enabling high-performance dual combination therapy (chemo/photothermal therapy). This style of novel nanocomposites was constructed with doxorubicin (DOX)-loaded mesoporous silica gold (MSG) nanorods, which were further camouflaged with hybrid membranes derived from HeLa cells and red blood cells (HRMSGD). The hybrid membrane-camouflaged structure showed enhanced circulation lifetime and cell line-specific delivery of chemotherapeutics both in vitro and in vivo. The dual combination therapy by HRMSGD showed an unattainable therapeutic effect, compared with a single treatment, and inhibited tumor growth significantly. Furthermore, the nanoplatforms were photoacoustic-responsive, which showed real-time and noninvasive tracking capability. The present study established nanoplatforms with hybrid cell membrane-camouflaged multifunctional gold nanorods, which realized the combination of homotypic targeting, noninvasive tracking, chemotherapy, and photothermal therapy. To the best of our knowledge, this is the first study to use a natural membrane to camouflage mesoporous silica-modified gold nanorods, which opened a new avenue for cancer treatment.Keywords
Funding Information
- State Key Laboratory of Respiratory Disease (SKLRD-QN-201924)
- National Natural Science Foundation of China (81330007, 81700382, 81870142, 81903607, 82072047, U1601227)
- Natural Science Foundation of Guangdong Province (2019A1515012166)
- Key Laboratory of Molecular Target and Clinical Pharmacology, Guangzhou Medical University (2018001)
This publication has 23 references indexed in Scilit:
- Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell MembranesNano Letters, 2016
- Biomimetic proteolipid vesicles for targeting inflamed tissuesNature Materials, 2016
- Hybrid nanoparticles for combination therapy of cancerJournal of Controlled Release, 2015
- Cell membrane-camouflaged nanoparticles for drug deliveryJournal of Controlled Release, 2015
- Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNABiomaterials, 2015
- Near Infrared Laser-Induced Targeted Cancer Therapy Using Thermoresponsive Polymer Encapsulated Gold NanorodsJournal of the American Chemical Society, 2014
- Photosensitizer-Loaded Gold Vesicles with Strong Plasmonic Coupling Effect for Imaging-Guided Photothermal/Photodynamic TherapyACS Nano, 2013
- Remote Triggered Release of Doxorubicin in Tumors by Synergistic Application of Thermosensitive Liposomes and Gold NanorodsACS Nano, 2011
- Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug ReleaseACS Nano, 2010
- Single-Step Coating of Mesoporous Silica on Cetyltrimethyl Ammonium Bromide-Capped NanoparticlesNano Letters, 2007